|
Volumn 34, Issue 12, 2002, Pages 1660-1662
|
Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIDANOSINE;
GANCICLOVIR;
INTERLEUKIN 2;
LOPINAVIR PLUS RITONAVIR;
STAVUDINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
AIDS RELATED COMPLEX;
CANCER RADIOTHERAPY;
CASE REPORT;
COMORBIDITY;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG MEGADOSE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
LARGE CELL LYMPHOMA;
LETTER;
LYMPHOCYTE COUNT;
MALE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADULT;
ANTI-HIV AGENTS;
ANTINEOPLASTIC AGENTS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
DRUG THERAPY, COMBINATION;
GANCICLOVIR;
HUMANS;
INTERLEUKIN-2;
LYMPHOMA, AIDS-RELATED;
MALE;
TREATMENT REFUSAL;
ZIDOVUDINE;
|
EID: 0037097508
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/340724 Document Type: Letter |
Times cited : (17)
|
References (10)
|